TRANSBUCCAL DELIVERY OF SPRAY DRIED LOVASTATIN FROM MUCOADHESIVE BUCCAL PATCHES AND IN VITRO CHARACTERIZATION
Objective: The aim of the present work was to develop and characterize mucoadhesive film of spray dried Lovastatin (LVS) for buccal delivery to enhance bioavailability.
Methods: Mucoadhesive films were prepared by solvent casting technique by using different polymers HPMCK4M, HPMC E5LV and chitosan. The successful patches were evaluated for film thickness, weight, content uniformity, surface pH, swelling index, folding endurance, ex-vivo residence time, ex-vivo bioadhesion test, in vitro drug release, ex-vivo drug permeation and stability study.
Results: The thickness of all prepared patches ranged from 0.21±0.07 to 1.5±0.39 mm, weight of the film 89.10±0.6 to 128.57±0.3 mg, drug content 85.47±0.87 to 97.33±0.31%, surface pH 5.6±0.67 to 7.6±0.98, swelling index 23.0±4.1 to 76.5±3.6%, folding endurance 165±1.9 to 350±2.5 respectively. Ex-vivo residence time ranged from 2.2±0.08to 8.2±0.17 h and ex-vivo bioadhesive strength 30±0.64 to 66±0.43 g. The formulations with HPMC E5 shown short period of residence time and shows weak force of adhesion., which might be because of low viscosity of the polymer which resulted into weak adhesion. The percentage drug release and ex-vivo drug permeation was in the following descending order HPMC K4M>HPMC E5LV>chitosan. These results confirm the extension of drug release in case of ionic polymer chitosan. The kinetics data shows that drug release and permeation follows nonfickian diffusion. Accelerated stability data revealed that there is no significant change in drug content, in vitro drug release and ex-vivo permeation.
Conclusion: It can be concluded that, mucoadhesive buccal patch is a promising dosage form to enhance the drug bioavailability by preventing first pass metabolism thus providing better therapeutic efficacy.
2) Meher J G, Tarai M, Yadav N P, Pathak A, Mishra P, Yadav K. Development and characterization of cellulose- polymethacrylatemucoadhesive film for buccal delivery of carvedilol. Carbohydrate polymers 2017; 96:172-180.
3) K. Chandra Sekhar, K. V. S. Naidu, Y. Vamshi Vishnu, Ramesh Gannu, V. Kishan, and Y. Madhusudan Rao. Transbuccal Delivery of Chlorpheniramine Maleate from Mucoadhesive Buccal Patches Drug Delivery 2008; 15:185–191.
4) Castan H, Ruiz B, Morales M, Design, Development and charecterisation of buccal bioadhesive films of Doxepin for treatment of odontalgia. Drug delivery 2017; 22(6):869-876.
5) Tripathi K D, Essentials of Medical pharmacology. 6th Ed; jaypee brothers medical publishers 2010:612-623.
6) Patel R P, Patel M M. Physicochemical charecterization and dissolution study of solid dispersions of lovastatin with PEG 4000 and Polyvinylpyrrolidone K30. Pharmaceutical development and technology 2007; 12:21-33.
7) Parfitt K. Lipid regulating drugs: Lovastatin, Martindale. 32nd Ed, The pharmaceutical press 1999:1275.
8) Gerald S. B.; Dean, K.E. Micheal J.K. Lovastatin. Analytical profiles of drug substances and excipients. Harry G. B. Ed.; Academic press: 1st Ed, Acadaemic press 1998:278-305.
9) Jagadale S, Hable A, Kuchekar B. Improvement of dissolution rate of Chlorzoxazone by Solid Dispersion technique and development of buccal patch. Journal of applied solution chemistry and modelling 2013; 2: 145-157.
10) Hassan M A, Barakat N S, El-Badry M Shehata S M. Formulation and in-vitro and in-vivo evaluation of Naproxen mucoadhesive buccal patches for local effect. Journal of drug delivery science and technology 2011; 21(5): 423-431.
11) Patel R P, Poddar S S. Deveopment and charecterization of mucoadhesive buccal patches of salbutamol sulphate. Current drug delivery 2009; 6: 140-144.
This work is licensed under a Creative Commons Attribution 4.0 International License.